Guide

The Part 2 consent: single-consent redisclosure explained

Summary

A 42 CFR Part 2 consent form must name the patient, the party disclosing, the party receiving, what information and how much, and the purpose. Since the 2024 rule, one consent can cover all future treatment, payment, and operations disclosures using a general designation like 'my treating providers.' It must also state that the consent is revocable, when it expires, carry the patient's signature and date, and be paired with a notice barring redisclosure.

By Gale Editorial · Updated 2026-07-26. Every figure cited to a dated source. How we write.

Revocation and expiration

Two elements do real work after signing: revocation and expiration. The consent must tell the patient they can revoke it at any time, and how; a revocation stops future disclosures, though it cannot undo disclosures already made in reliance on the consent 1. The consent must also state when it ends — a specific date, or an event or condition, such as 'the end of treatment' or 'one year from signing' 1.

For a solo practice, the practical move is to date-stamp every consent and diary the expiration, so you never disclose on a consent that has lapsed. Keep the signed consent as part of the record for your state's retention period, since you may need to show, years later, exactly what the patient authorized and when that authority ended 1.

Who signs: adults, minors, representatives

Usually the patient signs, but Part 2 has a specific rule for minors. Where state law lets a minor consent to their own SUD treatment, the minor — not the parent — must sign the Part 2 consent to release those records; where state law requires parental consent for treatment, the parent's signature is required or added 1. For an adult who lacks capacity, an authorized representative signs, again as state law and the regulation define 1.

This is one place Part 2 and general HIPAA practice can diverge, so do not assume a parent can always authorize release of a teen's SUD records. Confirm your state's minor-consent-to-treatment rule first; it decides who holds the pen. Whether Part 2 even reaches your setting is a separate threshold — part 2 and the private practice covers that test before you draft a single form 1.

The redisclosure notice you must attach

Every Part 2 disclosure made with consent must be accompanied by a written redisclosure notice telling the recipient the information is protected and may not be redisclosed without further authority — unless the recipient is a HIPAA covered entity or business associate receiving it for TPO under the new single-consent path 1. That notice is a required companion to the consent, not an optional courtesy 3.

Build it into your release workflow: the consent authorizes the disclosure, and the redisclosure notice travels with the records out the door. The 2024 alignment softened the redisclosure limit for HIPAA-covered TPO recipients, but for everyone else the old bar still holds, so keep the notice attached by default rather than deciding it case by case at the moment of release 3.

Common questions

Yes. Since the 2024 rule, a single consent can authorize future disclosures for treatment, payment, and health care operations, and can name recipients by a general designation such as 'my treating providers' rather than one at a time. The patient still signs, and the form must state the purpose, expiration, and revocation right.

The patient's name; who may disclose; who receives (by name or permitted general designation); the amount and kind of information; the purpose; a statement that the consent is revocable and how; an expiration date, event, or condition; and the signature and date. Omitting any required element can make the disclosure unlawful.

Yes. Every Part 2 consent must state an expiration — a specific date, or an event or condition such as the end of treatment. It is also revocable at any time. A practical safeguard is to diary each consent's expiration so you never release records on authority that has already lapsed.

It depends on state law. Where the state lets a minor consent to their own substance-use treatment, the minor signs the Part 2 consent to release those records. Where the state requires parental consent for the treatment, the parent signs or co-signs. Confirm your state's minor-consent rule before assuming a parent controls the release.

Yes, as a default. Disclosures made with consent must carry a written notice barring redisclosure without further authority. The 2024 alignment eased that limit only for HIPAA covered entities and business associates receiving records for treatment, payment, or operations; for every other recipient the notice still applies, so keep it attached routinely.

Run your practice on Gale

The software is free. Gale earns one flat 3.5% all-in per paid transaction — only on transactions that actually pay. No subscription, no setup fee, no network cut.

Start or manage a practice →

References

  1. 1.Office of the Federal Register (2026). 42 CFR Part 2 — Confidentiality of Substance Use Disorder Patient Records. eCFR. linkThe required content elements of a Part 2 consent, the revocation and expiration requirements, the minor-consent rule, the redisclosure-notice requirement, and the limits on what consent can accomplish.
  2. 2.U.S. Department of Health and Human Services (2024). Fact Sheet: 42 CFR Part 2 Final Rule. U.S. Department of Health and Human Services. linkThe 2024 single-consent-for-future-TPO change and the use of a general designation for recipients, summarized as what changed for the consent form.
  3. 3.Substance Abuse and Mental Health Services Administration (2024). Confidentiality of Substance Use Disorder (SUD) Patient Records. Federal Register. linkThe operative text creating the patient's right to a list of TPO disclosures made under a general designation and the redisclosure-notice requirement as published in the final rule.
  4. 4.National Association of Social Workers (2021). NASW Code of Ethics. National Association of Social Workers. linkThat informed consent is an ethics obligation requiring the client to understand the scope and their revocation right, so the consent form must be treated as a conversation, not just a signature.

https://www.gale.care/for-providers/pr-part2-consent-forms · 4 sources. Competitor details are cited to dated public sources and maintained as they change; figures are estimates, not commitments. Synthetic demonstration.

Findability, by specialty

How practices like yours get found in local search and AI answers — the honest playbook, per specialty.

SEO for private practices · SEO for AI search / answer engines (all verticals)